Peter A. Thompson

Companies

• Sionna Therapeutics, Inc.Board member Feb 6, 2025 to now¹
• Edgewise Therapeutics, Inc.Board member Mar 25, 2021 to now²
• Silverback TherapeuticsBoard member Dec 3, 2020 to now³
• Corvus Pharmaceuticals, Inc.Board member Mar 22, 2016 to now⁴
• Alpine Immune SciencesBoard member Jul 26, 2017 to May 20, 2024⁵
• Decibel Therapeutics, Inc.Board member Feb 11, 2021 to Jun 21, 2022⁶
• Janux Therapeutics, Inc.Board member Jun 10, 2021 to Jun 16, 2022⁷
• PMV Pharmaceuticals, Inc.Board member Sep 24, 2020 to Jun 9, 2021⁸
• Principia Biopharma (United States)Board member Sep 13, 2018 to Sep 13, 2018⁹
• Adaptimmune (United Kingdom)Board member Jan 4, 2016 to Jun 6, 2018¹⁰
• Sierra Oncology, Inc.Board member Jul 15, 2015 to Jul 21, 2015¹¹
• Mirati Therapeutics, Inc.Board member Jul 12, 2013 to Jul 12, 2013¹²
• Anthera PharmaceuticalsBoard member Feb 10, 2011 to May 10, 2012¹³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CPCorvus Pharmaceuticals, Inc. CRVS8,819,091 shares¹⁴$84.8M at $9.61Jan 30, 2026
• Silverback Therapeutics SPRY8,019,187 shares¹⁵$34.4M at $4.29Aug 28, 2024
• ETEdgewise Therapeutics, Inc. EWTX443,792 shares¹⁶$16.8M at $37.85Apr 3, 2025
• STSionna Therapeutics, Inc. SION2,469,959 shares¹⁷$10.1M at $4.07Jul 7, 2026
• JTJanux Therapeutics, Inc. JANX231,098 shares¹⁸$3.8M at $16.60Dec 29, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 7, 2026Sold 85,918 shares at $44.86 of Sionna Therapeutics, Inc.¹⁷
• Jun 30, 2026Sold 115,844 shares at $45.50 of Sionna Therapeutics, Inc.¹⁹
• May 27, 2026Sold 101 shares at $44.49 of Sionna Therapeutics, Inc.²⁰
• May 11, 2026Sold 184,639 shares at $46.22 of Sionna Therapeutics, Inc.²¹
• May 8, 2026Sold 59,767 shares at $44.58 of Sionna Therapeutics, Inc.²¹
• May 7, 2026Sold 48,546 shares at $44.61 of Sionna Therapeutics, Inc.²¹
• Apr 18, 2026Sold 2,948 shares at $44.52 of Sionna Therapeutics, Inc.²²
• Apr 17, 2026Sold 52,397 shares at $44.68 of Sionna Therapeutics, Inc.²²
• Apr 16, 2026Sold 226,906 shares at $45.34 of Sionna Therapeutics, Inc.²³
• Apr 15, 2026Sold 235,863 shares at $44.64 of Sionna Therapeutics, Inc.²³
• Apr 14, 2026Sold 47,814 shares at $44.51 of Sionna Therapeutics, Inc.²³
• Feb 3, 2026Sold 29,063 shares at $44.58 of Sionna Therapeutics, Inc.²⁴
• Feb 2, 2026Sold 1,890 shares at $44.57 of Sionna Therapeutics, Inc.²⁴
• Jan 28, 2026Exercised options 15,000 shares at $2.12 of Corvus Pharmaceuticals, Inc.¹⁴
• Jan 28, 2026Exercised options 15,000 shares at $1.64 of Corvus Pharmaceuticals, Inc.¹⁴
• Jan 28, 2026Exercised options 15,000 shares at $2.49 of Corvus Pharmaceuticals, Inc.¹⁴
• Jan 28, 2026Exercised options 15,000 shares at $0.97 of Corvus Pharmaceuticals, Inc.¹⁴
• Jan 28, 2026Exercised options 15,000 shares at $0.99 of Corvus Pharmaceuticals, Inc.¹⁴
• Jan 28, 2026Exercised options 15,000 shares at $2.60 of Corvus Pharmaceuticals, Inc.¹⁴
• Jan 28, 2026Exercised options 15,000 shares at $2.74 of Corvus Pharmaceuticals, Inc.¹⁴
• Jan 28, 2026Exercised options 15,000 shares at $3.27 of Corvus Pharmaceuticals, Inc.¹⁴
• Jan 28, 2026Exercised options 15,000 shares at $2.00 of Corvus Pharmaceuticals, Inc.¹⁴
• Jan 28, 2026Exercised options 15,000 shares at $3.61 of Corvus Pharmaceuticals, Inc.¹⁴
• Jan 28, 2026Exercised options 15,000 shares at $12.50 of Corvus Pharmaceuticals, Inc.¹⁴
• Jan 28, 2026Exercised options 15,000 shares at $9.70 of Corvus Pharmaceuticals, Inc.¹⁴